Incidence of CDI in a Cohort of US Patients with Newly Diagnosed Acute Myeloid Leukemia Receiving Intensive Chemotherapy

被引：0
|
作者：
Lurienne, Lise
Le Bescop, Clement
Buffet, Renaud
Bandinelli, Pierre-Alain
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Incidence of CDI in a Cohort of US Patients with Newly Diagnosed Acute Myeloid Leukemia Receiving Intensive Chemotherapy
    Lurienne, Lise
    Le Bescop, Clement
    Buffet, Renaud
    Bandinelli, Pierre-Alain
    BLOOD, 2020, 136
  • [2] Incidence of CDI and Association with Antibiotics in a Cohort of Patients with Newly Diagnosed Acute Myeloid Leukemia Receiving Induction Chemotherapy
    Jakob, Carolin
    Bauquet, Aurelie
    Buffet, Renaud
    Vehreschild, Maria
    Vehreschild, Janne
    BLOOD, 2020, 136
  • [3] Economic burden in US patients with newly diagnosed acute myeloid leukemia receiving intensive induction chemotherapy
    Huggar, David
    Knoth, Russell L.
    Copher, Ronda
    Cao, Zhun
    Lipkin, Craig
    McBride, Ali
    LeBlanc, Thomas W.
    FUTURE ONCOLOGY, 2022, 18 (32) : 3609 - 3621
  • [4] Decitabine Versus Intensive Chemotherapy for Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
    Choi, Eun-Ji
    Lee, Je-Hwan
    Park, Han-Seung
    Lee, Jung-Hee
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Woo, Ji Min
    Lee, Kyoo-Hyung
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (05): : 290 - +
  • [5] Decitabine Versus Intensive Chemotherapy for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia
    Choi, Eun-Ji
    Lee, Je-Hwan
    Park, Han-Seung
    Lee, Jung-Hee
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Woo, Ji Min
    Lee, Kyoo Hyung
    BLOOD, 2018, 132
  • [6] Healthcare Resource Utilization and Costs in US Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Intensive Induction Chemotherapy
    Huggar, David
    Knoth, Russell L.
    Copher, Ronda
    Cao, Zhun
    Lipkin, Craig
    McBride, Ali
    LeBlanc, Thomas W.
    BLOOD, 2021, 138
  • [7] Risk Stratification of Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia Unfit for Intensive Chemotherapy
    Gardeney, Helene
    Diaz, Jose Miguel Torregrosa
    Basle, Caroline
    Cayssials, Emilie
    Bouyer, Sabrina
    Moya, Niels
    Gruchet, Cecile
    Sabirou, Florence
    Bobin, Arthur
    Levy, Anthony
    Nsiala, Laly
    Cailly, Laura
    Vonfeld, Mathilde
    Desmier, Deborah
    Leleu, Xavier
    Hernanz, Maria Pilar Gallego
    BLOOD, 2021, 138
  • [8] Outcomes of Adult Patients with Newly Diagnosed IDH-Mutated Acute Myeloid Leukemia Receiving Intensive Chemotherapy Plus Venetoclax
    Croden, Jennifer
    Marvin-Peek, Jennifer
    Konopleva, Marina
    Borthakur, Gautam
    Daver, Naval
    Abbas, Hussein A.
    Takahashi, Koichi
    Sasaki, Koji
    Garcia-Manero, Guillermo
    Jain, Nitin
    Pemmaraju, Naveen
    Short, Nicholas J.
    Hammond, Danielle
    Jabbour, Elias
    Masarova, Lucia
    Chien, Kelly S.
    Issa, Ghayas C.
    Montalban-Bravo, Guillermo
    Yilmaz, Musa
    Maiti, Abhishek
    Valero, Yesid Alvarado
    Kornblau, Steven M.
    Ravandi, Farhad
    Kantarjian, Hagop
    Kadia, Tapan M.
    Dinardo, Courtney D.
    BLOOD, 2024, 144 : 6126 - 6128
  • [9] Venetoclax for the treatment of newly diagnosed acute myeloid leukemia in patients who are ineligible for intensive chemotherapy
    Richard-Carpentier, Guillaume
    DiNardo, Courtney D.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10
  • [10] Intensive Chemotherapy in Patients Aged 70 Years or Older Newly Diagnosed With Acute Myeloid Leukemia
    Ross, Kelly
    Gillespie-Twardy, Amanda L.
    Agha, Mounzer
    Raptis, Anastasios
    Hou, Jing-Zhou
    Farah, Rafic
    Redner, Robert L.
    Im, Annie
    Duggal, Shrina
    Ding, Fei
    Lin, Yan
    Boyiadzis, Michael
    ONCOLOGY RESEARCH, 2014, 22 (02) : 85 - 92
12345